Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum N-Glycan Profiling Identifies Candidate Glycan Biomarkers for Early Detection and Prediction of Alzheimer’s Disease

12 Aug 2025

Abstract excerpt

Alzheimer’s disease (AD) is a neurodegenerative disorder marked by progressive cognitive decline, affecting millions worldwide. Early diagnosis and intervention are crucial yet challenging, particularly in distinguishing between Mild Cognitive Impairment (MCI) subtypes, which often precede AD. Recent studies have highlighted the significant role of glycosylation, specifically N -glycan alterations, in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Carbohydrate Chemistry and Synthesis
Share to Glycosylation and Glycoproteins Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40792479
DOI: 10.1021/acs.jproteome.5c00018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum N-Glycan Profiling Identifies Candidate Glycan Biomarkers for Early Detection and Prediction of Alzheimer’s DiseasePMID 40792479Read ↗

Early Stage Glycosylation Biomarkers in Alzheimer’s DiseaseSemantic proximity Read ↗

Human brain glycoform co-regulation network and glycan modification alterations in Alzheimer’s diseaseSemantic proximity Read ↗

Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s diseaseSemantic proximity Read ↗

Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer’s diseaseSemantic proximity Read ↗

Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer’s diseaseSemantic proximity Read ↗

CSF N-glycoproteomics for early diagnosis in Alzheimer's diseaseSemantic proximity Read ↗

Multilayered N-glycoproteomics reveals impaired N-glycosylation promoting Alzheimer’s diseaseSemantic proximity Read ↗

Implications of Glycosylation in Alzheimer’s DiseaseSemantic proximity Read ↗

Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkersSemantic proximity Read ↗

Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid.Semantic proximity Read ↗

Hyper-Glycosylation as a Central Metabolic Driver of Alzheimer’s DiseaseSemantic proximity Read ↗

Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral SclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.